| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048650802 |
| P356 | DOI | 10.1186/1472-6882-14-159 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/1472-6882-14-159 |
| P932 | PMC publication ID | 4032499 |
| P698 | PubMed publication ID | 24886572 |
| P5875 | ResearchGate publication ID | 262788927 |
| P50 | author | Yves Henrotin | Q59556277 |
| P2093 | author name string | Myriam Gharbi | |
| Adelin Albert | |||
| Marc Marty | |||
| Laurence Seidel | |||
| Fabian Priem | |||
| Valérie Bonnet | |||
| Caroline Castermans | |||
| Elisabeth Heuse | |||
| Yvan Dierckxsens | |||
| P2860 | cites work | Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients. | Q51226364 |
| The pharmacology of curcumin: is it the degradation products? | Q53326705 | ||
| Suppression of NF-κB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis | Q58629377 | ||
| Coll2-1, Coll2-1NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands | Q60467811 | ||
| Type II collagen peptides for measuring cartilage degradation | Q80426071 | ||
| One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement | Q80651272 | ||
| The chemical biomarkers C2C, Coll2-1, and Coll2-1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice | Q81377189 | ||
| New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis | Q81433688 | ||
| Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis | Q83320010 | ||
| Usefulness of specific OA biomarkers, Coll2-1 and Coll2-1NO2, in the anterior cruciate ligament OA canine model | Q83793605 | ||
| Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis | Q84382401 | ||
| Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO₂ ) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: a research study part of the Biovisco study | Q86169284 | ||
| Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence | Q21195656 | ||
| Nutraceutical-definition and introduction | Q24647970 | ||
| EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) | Q24674132 | ||
| EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). | Q31119321 | ||
| OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence | Q33295110 | ||
| OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines | Q33320085 | ||
| OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. | Q33532831 | ||
| Biological actions of curcumin on articular chondrocytes. | Q34019795 | ||
| Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. | Q34027184 | ||
| Nutraceuticals: do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products | Q34146992 | ||
| Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment | Q34152916 | ||
| Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases | Q34594807 | ||
| Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets | Q34602448 | ||
| Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. | Q34626068 | ||
| Curcumin as "Curecumin": from kitchen to clinic. | Q34694680 | ||
| Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals | Q35129349 | ||
| Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study | Q36392984 | ||
| Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis | Q36598469 | ||
| Collagen catabolism through Coll2-1 and Coll2-1NO2 and myeloperoxidase activity in marathon runners | Q36695278 | ||
| Type II collagen markers in osteoarthritis: what do they indicate? | Q36925336 | ||
| Multi-targeted therapy by curcumin: how spicy is it? | Q37126542 | ||
| Osteoarthritis: a tale of three tissues. | Q37304243 | ||
| Curcumin reduces prostaglandin E2, matrix metalloproteinase-3 and proteoglycan release in the secretome of interleukin 1β-treated articular cartilage | Q37513443 | ||
| Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs | Q37798220 | ||
| Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers | Q38083084 | ||
| Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management | Q38088973 | ||
| Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association | Q39513001 | ||
| A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis | Q39642357 | ||
| Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis | Q42909168 | ||
| Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. | Q44789264 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | osteoarthritis | Q62736 |
| curcumin | Q312266 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | 159 | |
| P577 | publication date | 2014-05-17 | |
| P1433 | published in | BMC Complementary and Alternative Medicine | Q15755965 |
| P1476 | title | Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial | |
| P478 | volume | 14 |
| Q34675414 | Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q46310171 | Anti-inflammatory effects of polyphenols in arthritis. |
| Q28071711 | Benefits of antioxidant supplements for knee osteoarthritis: rationale and reality |
| Q92221515 | Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study |
| Q57811100 | Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives |
| Q35644533 | Chondroprotective effects of Salubrinal in a mouse model of osteoarthritis. |
| Q88325112 | Comparative evaluation of therapeutic efficacy of intra-articular oxaceprol with conventional modalities in osteoarthritis animal model |
| Q90603268 | Curcumin Inhibits Proliferation of Synovial Cells by Downregulating Expression of Matrix Metalloproteinase-3 in Osteoarthritis |
| Q47159374 | Curcumin and normal functioning of joints: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| Q36044826 | Curcumin attenuates brain edema in mice with intracerebral hemorrhage through inhibition of AQP4 and AQP9 expression |
| Q90088381 | Curcumin effects on myeloperoxidase, interleukin-18 and matrix metalloproteinase-9 inflammatory biomarkers in patients with unstable angina: A randomized clinical trial |
| Q38957154 | Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. |
| Q51019313 | Curcumin-loaded nanoliposomes linked to homing peptides for integrin targeting and neuropilin-1-mediated internalization. |
| Q93201443 | Current status of top 10 nutraceuticals used for Knee Osteoarthritis in India |
| Q42199082 | Decrease of serum biomarker of type II Collagen degradation (Coll2-1) by intra-articular injection of an autologous plasma-rich-platelet in patients with unilateral primary knee osteoarthritis |
| Q49639609 | Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. |
| Q89737254 | Increased Urinary Concentration of C-Terminal Telopeptide of Type II Collagen and Pain by Radiographic Grade in Women with Knee Osteoarthritis in Northeastern Mexico: A Cross-Sectional Study |
| Q33794384 | Isothiocyanates are detected in human synovial fluid following broccoli consumption and can affect the tissues of the knee joint |
| Q49981865 | Oral curcumin supplementation improves fine motor function in the middle-aged rhesus monkey. |
| Q26771893 | Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria |
| Q33733817 | Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized |
| Q89662487 | Responses to "Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study": authors' reply |
| Q28076995 | The spice for joint inflammation: anti-inflammatory role of curcumin in treating osteoarthritis |
Search more.